Resmed (RMD) Tax Provisions (2009 - 2026)

Resmed has reported Tax Provisions for 18 years, with the latest figure at $103.6 million in Q1 2026.

• For the quarter ending Q1 2026, Tax Provisions rose 96.73% year-over-year to $103.6 million; the trailing twelve-month figure through Mar 2026 stood at $383.7 million (up 45.36% YoY), and the FY2025 full-year result was $276.8 million, up 13.53% from the prior year.
• Tax Provisions for Q1 2026 stood at $103.6 million, roughly flat from $103.6 million in the prior quarter.
• The five-year high for Tax Provisions was $103.6 million in Q1 2026, with the low at $43.0 million in Q2 2022.
• Historically, Tax Provisions has averaged $65.9 million across 5 years, with a median of $56.9 million in 2023.
• Annual changes were most pronounced in 2022 — Tax Provisions sank 84.04% — and 2026, when it jumped 96.73%.
• Resmed's Tax Provisions stood at $48.8 million in 2022, then grew by 3.85% to $50.7 million in 2023, then soared by 45.5% to $73.7 million in 2024, then surged by 40.51% to $103.6 million in 2025, then rose by 0.02% to $103.6 million in 2026.
• The last three Tax Provisions figures came in at $103.6 million (Q1 2026), $103.6 million (Q4 2025), and $98.3 million (Q3 2025), per Business Quant data.